SEC Filing Summary: CVS HEALTH Corp (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by CVS HEALTH Corp, an institutional investment manager, reporting its equity holdings. The report covers the quarter ended June 30, 2026, and was signed on August 6, 2026, by Michael Motolo, Executive Director.
Key Financial Metrics
As a Form 13F filing, this document discloses investment portfolio holdings rather than the company's operational financial performance. Consequently, the following operational metrics are not applicable to this filing:
- Revenue, Profit, Cash Flow, Margins: Not reported in this filing.
- Debt and Liquidity: Not reported in this filing.
Portfolio Metrics Reported:
- Total Number of Holdings: 21 entries.
- Total Value of Reported Holdings: $225,165,890.
- Other Included Managers: None.
Material Changes
The filing text does not provide a comparative table or narrative detailing changes in holdings versus the prior comparable period. It only states the total count and value of holdings for the current quarter.
Guidance, Outlook, and Risks
This filing type does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding CVS HEALTH Corp's business operations. It strictly lists securities held for investment purposes.
Investor Verification Checklist
- Verify the total portfolio value of $225,165,890 against the sum of individual security values in the full schedule (not provided in this summary text).
- Confirm the specific 21 securities held to understand the investment strategy (e.g., concentration in healthcare vs. diversification).
- Note that this filing reflects investment assets managed by CVS HEALTH Corp, not the operating results of the CVS HEALTH Corp business itself.
- Check for any subsequent amendments, as this report was filed on August 6, 2026.